Websites using metastatic as a keyword
Here you can see a list of websites which are using metastatic as keyword according to our database.
Websites found: 31
Number of websited displayed: 31
List of results:
Prostate Cancer Foundation of Australia - PCFAhttp://site-overview.com/stats/prostate.org.au
PCFA is a broad based community organisation dedicated to reducing the impact of prostate cancer on Australian men, their partners and families
- Known AddThis user account: ra-51baa4744fe323b0
- Google Analytics ID: 23518974-2
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCPhttp://site-overview.com/stats/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
- Website Address renewal date: 17/9/3
- Domain Address Reg. date: 05/10/5
- Website address in use until: 18/10/5
Jevtana® (cabazitaxel) Injection | Advanced Prostate Cancerhttp://site-overview.com/stats/jevtana.com
Jevtana® (cabazitaxel) Injection is indicated for treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
- Website Address renewal date: 16/7/19
- Domain Address Reg. date: 02/7/23
- Website address in use until: 18/7/23
The American Association of Endocrine Surgeons - Patient Education Sitehttp://site-overview.com/stats/endocrinediseases.org
The American Association of Endocrine Surgeons is dedicated to the diagnosis, treatment, and study of endocrine disease. We created this site to help you and your loved ones find comprehensive, unbiased information about these diseases. Our goal is to provide you with all the knowledge you need to find the best possible care.
- Google Analytics ID: 25839029-1
- Website Address renewal date: 16/8/21
- Domain Address Reg. date: 10/10/16
- Website address in use until: 18/10/16
AIM Biotech - 3D cell culturehttp://site-overview.com/stats/aimbiotech.com
AIM Biotech offers an easy-to-use, modular platform for incorporating 3D cell culture into your research. AIM chips enable you to co-culture different cell types discrete 3D and 2D compartments, using hydrogels of your choice. Other important parameters
- Google Analytics ID: 55224757-1
- Website Address renewal date: 17/6/16
- Domain Address Reg. date: 11/6/16
- Website address in use until: 18/6/16
Gamma Knife – CENTRO DE TRATAMIENTO DE TUMORES CEREBRALEShttp://site-overview.com/stats/gammaknife.com.ec
Gamma Knife®, también identificada como SRS o radiocirugía estereotáctica, es una cirugía de alta tecnología que ha sido diseñada para aplicar –con extrema precisión– altas dosis de radiación, enfocando específicamente el tumor, gracias a lo cual se ocasiona un daño mínimo del tejido circundante, es posible tratar múltiples tumores en una sola sesión o atender la reaparición de estos en subsiguientes sesiones de radiocirugía, la disminución de efectos secundarios de quienes son tratados bajo esta revolucionaria técnica quirúrgica.
- Google Analytics ID: 57677460-5
- Website address in use until: 20/2/13
- Domain Address Reg. date: 17/2/13
OPDIVO® (nivolumab) | Patient Gatewayhttp://site-overview.com/stats/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Website Address renewal date: 16/11/1
- Domain Address Reg. date: 12/11/6
- Website address in use until: 17/11/6
ONIVYDE® (irinotecan liposome injection) | MM-398 | Official Sitehttp://site-overview.com/stats/onivyde.com
ONIVYDE® (irinotecan liposome injection) in combination for patients with metastatic pancreatic cancer previously treated with gemcitabine. See Important Safety Information, including Boxed Warning.
- Google Analytics ID: 68690796-1
- Website Address renewal date: 17/6/15
- Domain Address Reg. date: 13/7/1
- Website address in use until: 25/7/1
Metastatic CR Prostate Cancer Treatment - XTANDI® (enzalutamide)http://site-overview.com/stats/xtandihcp.com
Learn about XTANDI® (enzalutamide) capsules indicated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
- Website Address renewal date: 15/7/1
- Domain Address Reg. date: 12/7/10
- Website address in use until: 18/7/10
Choose GLIVEC® (imatinib) for KIT+ GISThttp://site-overview.com/stats/glivec.com
GLIVEC® (imatinib) is indicated for the treatment of unresectable and/or metastatic and adjuvant KIT+ GIST.
- Website Address renewal date: 16/5/21
- Domain Address Reg. date: 00/6/22
- Website address in use until: 18/6/22
Homehttp://site-overview.com/stats/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
- Website Address renewal date: 16/8/9
- Domain Address Reg. date: 99/8/13
- Website address in use until: 17/8/13
Tyme Technologies | Fighting Stage IV Metastatic Cancerhttp://site-overview.com/stats/tymeinc.com
Tyme Technologies, Inc. is a research and development company focused on creating medicines that utilizes the body’s immune system to treat diseases.
- Google Analytics ID: 2555965-33
- Website Address renewal date: 17/5/19
- Domain Address Reg. date: 13/8/30
- Website address in use until: 20/5/19
Most Comprehensive Bowel Cancer Resource - Bowel Cancer Australiahttp://site-overview.com/stats/bowelcanceraustralia.org
Bowel Cancer Australia is dedicated to prevention, early diagnosis, research, quality treatment and care for everyone affected by bowel cancer (also known as colorectal cancer).
- Website Address renewal date: 15/12/31
- Domain Address Reg. date: 07/4/11
- Website address in use until: 24/4/11
Prostate Cancer Foundation of Australia | PCFAhttp://site-overview.com/stats/pcfa.org.au
PCFA is a broad based community organisation dedicated to reducing the impact of prostate cancer on Australian men, their partners and families
- Known AddThis user account: ra-51baa4744fe323b0
- Google Analytics ID: 23518974-2
C101 - A Unique Resource for People with Cancerhttp://site-overview.com/stats/cancer101.org
CANCER101 helps the newly diagnosed, those with metastatic cancer, their families and health care professionals work together to get organized and informed to
- Google Analytics ID: 39167303-1
- Website Address renewal date: 17/1/26
- Domain Address Reg. date: 02/2/9
- Website address in use until: 20/2/9
GIOTRIF® (afatinib) - | Boehringer Ingelheimhttp://site-overview.com/stats/giotrif.com
GIOTRIF® (afatinib) -
- Google Analytics ID: 44006287-1
- Website Address renewal date: 16/6/19
- Domain Address Reg. date: 07/6/20
- Website address in use until: 18/6/20
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://site-overview.com/stats/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Website Address renewal date: 17/2/27
- Domain Address Reg. date: 14/3/3
- Website address in use until: 18/3/3
For Healthcare Professionals | CYRAMZA® (ramucirumab)http://site-overview.com/stats/cyramzahcp.com
CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
- Website Address renewal date: 16/8/23
- Domain Address Reg. date: 13/8/27
- Website address in use until: 17/8/27
Cancer Carehttp://site-overview.com/stats/cancercarenews.ca
- Google Analytics ID: 47477110-23
- Website Address renewal date: 17/1/12
- Domain Address Reg. date: 14/1/29
- Website address in use until: 18/1/29
Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)http://site-overview.com/stats/cyramza.com
CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
- Website Address renewal date: 17/10/1
- Domain Address Reg. date: 11/10/5
- Website address in use until: 18/10/5
Home | Prostate Cancer Mattershttp://site-overview.com/stats/prostatecancermatters.ca
Knowledge is power. Understand your choices for metastatic prostate cancer.
- Google Analytics ID: 4635106-55
- Website Address renewal date: 17/2/20
- Domain Address Reg. date: 14/3/6
- Website address in use until: 18/3/6
YERVOY®(ipilimumab) | Consumer | Gatewayhttp://site-overview.com/stats/yervoy.com
YERVOY® (ipilimumab), prescription medication. See Indication, Important Safety Information, and Boxed Warning.
- Website Address renewal date: 17/5/4
- Domain Address Reg. date: 09/5/8
- Website address in use until: 18/5/8
IRSA - RadioSurgery Associationhttp://site-overview.com/stats/irsa.org
Educational and hospital on Gamma Knife and Linac stereotactic radiosurgery for brain tumors and disorders.
- Website Address renewal date: 16/8/31
- Domain Address Reg. date: 97/10/29
- Website address in use until: 21/10/28
metastatic.orghttp://site-overview.com/stats/metastatic.org
- Website Address renewal date: 16/6/1
- Domain Address Reg. date: 01/5/31
- Website address in use until: 17/5/31
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)http://site-overview.com/stats/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
- Website Address renewal date: 17/10/6
- Domain Address Reg. date: 16/10/10
- Website address in use until: 18/10/10
Neurosurgery.Brain Tumor.Stroke.Head Injury.Pain.Paraplegiahttp://site-overview.com/stats/neurosurgery.tv
Neurosurgery.Brain Tumor.Stroke.Head Injury.Pain.Paraplegia
- Google Analytics ID: 71156232-1
- Website Address renewal date: 15/12/17
- Domain Address Reg. date: 06/5/18
- Website address in use until: 25/5/18
Leiomyosarcoma is a rare cancerhttp://site-overview.com/stats/leiomyosarcoma.info
Leiomyosarcoma - extensive medical information all levels, written by a doctor for patients and doctors, to educate for effective treatment decisions.
- Website Address renewal date: 17/5/8
- Domain Address Reg. date: 02/6/10
- Website address in use until: 19/6/10